Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion type Assertion NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_head.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion description "[The selective COX-2 inhibitor (NS398) reduced the contractile effect of serotonin in aortas from mice treated with vehicle or HS microparticles; however, this was not observed within mice treated with MetS microparticles, probably due to the ability of MetS microparticles to enhance prostacyclin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_provenance.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion evidence source_evidence_literature NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_provenance.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion SIO_000772 22110764 NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_provenance.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion wasDerivedFrom befree-2016 NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_provenance.
- NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_assertion wasGeneratedBy ECO_0000203 NP941245.RAZj_eiD2HsJuGjrKQijDTAxWWaiLNIfGzZzn6bF7tGZc130_provenance.